Synflorix

Synflorix

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig Pharma
Concise Prescribing Info
Contents
Pneumococcal polysaccharide & non-typeable H influenzae protein D conjugate vaccine, 10-valent adsorbed
Indications/Uses
Active immunisation of infants & childn from 6 wk-5 yr against disease caused by S pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F & cross-reactive serotype 19A (including sepsis, meningitis, pneumonia, bacteraemia & acute otitis media) & against acute otitis media caused by non-typeable H influenzae.
Dosage/Direction for Use
IM Infant from 6 wk-6 mth 3 primary doses w/ at least 1 mth interval between doses or alternatively, as part of routine immunisation programme, 2 primary doses given 2 mth apart. 1st dose may be given as early as 6 wk of age & booster dose may be given from 9 mth of age at least 6 mth after last primary dose. Preterm infant at least 27 wk gestation 4 doses consisting of 3 primary doses w/ 1st dose given at 2 mth & at least 1 mth interval between doses. Booster dose: At least 6 mth after last primary dose. Previously unvaccinated older infant & childn 12 mth-5 yr 2 doses w/ at least 2 mth interval between doses, 7-11 mth 2 doses w/ at least 1 mth interval between doses. 3rd dose: Recommended in 2nd yr w/ at least 2 mth interval.
Contraindications
Special Precautions
Not to be inj intravascularly or intradermally. Not for protection against pneumococcal serogroups. Not to be used as substitute routine immunization w/ diphtheria, tetanus or HIB vaccines. Postpone vaccination in patients w/ acute severe febrile illness. Thrombocytopenia or any coagulation disorder; syncope. Resp monitoring for 48-72 hr in very premature infant (≤28 wk of gestation) & previous history of resp immaturity. High-risk for pneumococcal disease (eg, childn w/ SCD, asplenia, HIV infection, chronic illness or w/ immunocompromising conditions).
Adverse Reactions
Loss of appetite, irritability, drowsiness, inj site pain, redness & swelling, fever (≥38°C) rectally (age <2 yr). Inj site induration, fever >39°C rectally (age <2 yr).
Drug Interactions
Adequate response may not be elicited w/ immunosuppressants.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07AL52 - pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated ; Belongs to the class of pneumococcal vaccines.
Presentation/Packing
Form
Synflorix vaccine (inj) (pre-filled syringe) 0.5 mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in